View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Frank Claassen
  • Frank Claassen

Fagron - Compounding for growth

•    New 40p report: Fagron is an excellent play on the structural growth drivers of personalized medication (e.g. demographics, drug shortages). •    It has high visibility on high single digit organic growth and in combination with Buy-and-build this offers double digit EBITDA growth.•    We reiterate our Buy with a TP of EUR 24 (was EUR 23) based on our SOTP and DCF on the back of 2% higher EBITDA estimates following Q1.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

Ageas: BNPP buys 9% stake from Fosun, overhang gone. Just Eat Takeaway.com: Preview 1Q24. Staffing sector: PageGroup 1Q24 trading update, weaker exit rates. Xior Student Housing: Basecamp contribution in kind earn-out

Thomas Vranken
  • Thomas Vranken

Fagron Growth engine keeps running

We updated our model following Fagron's recent 1Q24 update. While our prior estimates for FY24 and beyond largely remain in place, we pay special attention to Fagron's North American compounding services (CS) business (Boston/Wichita + Anazao), as well as the impact of the recent Polish regulatory change. Overall, our valuation continues to point to a TP of € 22, hence we maintain a Buy rating.

 PRESS RELEASE

Fagron publishes agenda for 2024 annual shareholders meeting and extra...

Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting Regulated information Nazareth (Belgium)/Rotterdam (The Netherlands), 12 April 2024 – 8AM CET Fagron publishes agenda for 2024 annual shareholders meeting and extraordinary general meeting The Board of Directors of Fagron NV invites shareholders to attend Fagron’s annual general meeting of shareholders and the extraordinary general meeting of shareholders on Monday 13 May 2024. AgendaThe agenda includes the discussion of the annual report, the approval of the annual financial stateme...

Thomas Vranken
  • Thomas Vranken

Fagron FIRST LOOK: 1Q24 conference call feedback

Following our earlier note on the 1Q24 results (LINK), we share our main takeaways from the conference call hosted by Fagron to discuss its 1Q24 results.

Oliver Metzger
  • Oliver Metzger

ODDO BHF Small & MIDCAP MORNING NEWS - 04/11/2024

Waga Energy offers an innovative start-up profile in the utilities sector: i/ disruptive technology in biogas treatment, ii/ established competitive advantages, iii/ positioning on a market with strong potential (>20,000 landfills) and iv/ a robust business model based on recurring revenues. At its CMD in February 2024, the company reconfirmed its ambitions for 2026 set out at the IPO (contracts for 4 TWh and recurring revenues of € 200m). The financing secured in Q1 2024 (€ 112m base...

Oliver Metzger
  • Oliver Metzger

ODDO BHF Small & MIDCAP MORNING NEWS - 11/04/2024

Waga Energy propose un profil de start-up innovante dans le secteur des utilities : i/ une technologie disruptive pour le traitement du biogaz, ii/ des avantages compétitifs établis, iii/ un positionnement sur un marché à fort potentiel (>20 000 décharges) et iv/ un modèle robuste de revenus récurrents. La société a reconfirmé lors du CMD en février 2024 ses ambitions à horizon 2026 annoncées au moment de son IPO (signature de 4 TWh et CA récurrent de 200 M€). Fort des financements ob...

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

B&S Group: Preview - managing costs. CM.com: Preview 1Q24. Exor: FY23 results show solid 33% YoY NAV per share growth, beating INGF. Fagron: Solid organic performance in 1Q24, driven by Compounding activities

Guy Sips ... (+4)
  • Guy Sips
  • Hilde Van Boxstael
  • Thomas Vranken
  • Wim Lewi
Robert Jan Vos ... (+2)
  • Robert Jan Vos
  • Salome Charamalet

Fagron N.V. : Strong set of Q1 2024 results, 1.5% beat on consensus

>+14.9% of CER revenue growth, driven by strong EMEA and North America - In EMEA, Fagron reported revenue growth 10.3% higher than Q1 2023 (revenue at CER) with a 7% miss on beat (css: € 74.6m) driven by Compounding Services (+32.4%) and partly offset by Brands and Essentials (-3.9% and +3.5%). B&E reflects the impact of the new reimbursement system in Poland, mostly offset by solid performance in other countries. Compounding Services revenue growth of 32.4% (CER) is ...

Thomas Vranken
  • Thomas Vranken

Fagron FIRST LOOK: Solid 1Q24 results, EMEA outperforms expectations

Fagron's 1Q24 revenue shows strong performance in key regions with topline reaching € 209m (+15% y/y), driven by sustained high growth in N-Am's compounding activities and the Polish regulatory impact being offset by other countries in EMEA. We maintain our € 22.0 price target and Buy rating.

 PRESS RELEASE

Record revenue of €209 million in first quarter reflecting 15% topline...

Record revenue of €209 million in first quarter reflecting 15% topline growth Regulated information - inside informationNazareth (Belgium)/Rotterdam (The Netherlands), 11 April 2024 – 7:00 AM CET Record revenue of €209 million in first quarter reflecting 15% topline growth Fagron, the leading global player in pharmaceutical compounding today publishes its quarterly results for the period ending 31 March 2024. Key Highlights Revenue growth accelerated to 15.3% reported growth (14.9% at CER) resulting in €209.2 million, supported by all regionsOrganic growth at CER of 12.3% reflects the ...

 PRESS RELEASE

Recordomzet van €209 miljoen in eerste kwartaal en 15% omzetgroei

Recordomzet van €209 miljoen in eerste kwartaal en 15% omzetgroei Gereglementeerde informatie - voorwetenschapNazareth (België)/Rotterdam (Nederland), 11 april 2024 – 7u CET Recordomzet van €209 miljoen in eerste kwartaal en 15% omzetgroei Fagron, de toonaangevende mondiale speler in farmaceutische bereidingen, publiceert vandaag haar kwartaalresultaten voor de periode eindigend 31 maart 2024. Kernpunten Omzetgroei versnelde naar 15,3% gerapporteerde groei (14,9% tegen CER) resulterend in omzet van €209,2 miljoen, gedreven door alle regio’sOrganische omzetgroei van 12,3% tegen CER refle...

Frank Claassen
  • Frank Claassen

Fagron - A flying start

•    The Q1-24 organic growth of 12% nicely exceeded our 10%, driven by a strong performance in compounding services in both US and EMEA.•    Fagron can comfortably reiterate its FY24 guidance of high single digit organic growth. We see room to slightly increase our estimates by 1-2%.•    We reiterate our Buy and our TP of EUR 23, based on our 2025E SOTP and backed by our DCF.

ING Helpdesk
  • ING Helpdesk

Benelux Morning Notes

ASML: Preview 1Q24 – Building momentum. Fastned: Preview 1Q24 trading update. TomTom: Preview 1Q24, limited changes vs FY23. Xior Student Housing: Final formal step for the Basecamp deal

Fernand de Boer
  • Fernand de Boer

Colruyt - Inflation tailwind ending

In the past year, Colruyt group unlocked most of the hidden value especially through the sale of Parkwind. It also simplified the structure and created more focus within the company. This is now all reflected in the numbers. With food CPI in Belgium dropping below general CPI, the “favorable” inflation conditions will come to end. Hence, after the very strong rise in earnings in FY23/24, we expect limited earnings growth in the coming years.Given the limited earnings growth, and with most of the...

Guy Sips ... (+7)
  • Guy Sips
  • Hilde Van Boxstael
  • Jacob Mekhael
  • Sharad Kumar S.P
  • Thomas Couvreur
  • Thomas Vranken
  • Wim Lewi
Anis Zgaya ... (+2)
  • Anis Zgaya
  • Philippe Ourpatian

ODDO BHF Small & MIDCAP MORNING NEWS - 27/03/2024 Date Performance dep...

Rieter est leader mondial dans les équipements de filature à fibres courtes destinés au marché textile. Il s’agit d’une activité à cycles courts (4 ans en moyenne) dont l’exercice 2024 devrait représenter un point bas avec un CA proche de 1 MdCHF (-28% y-o-y). Le programme de performance « Next Level », présenté en juillet 2023, devrait permettre de réduire la cyclicité du business model et de revenir sur des niveaux normatifs de rentabilité (c. 6% de marge d’EBIT). Rieter est donc en...

Anis Zgaya ... (+2)
  • Anis Zgaya
  • Philippe Ourpatian

ODDO BHF Small & MIDCAP MORNING NEWS - 03/27/2024 Date Performance sin...

Rieter is the world’s leading supplier of short-staple fibre spinning equipment designed primarily for textile, a short-cycle business that spans four years on average. The group is set to hit a low in 2024 with close to CHF 1bn in revenues, down 28% YoY. Next Level, a performance programme presented in July 2023, should enable the group to reduce the cyclicality of its business model and return to normal profitability with around 6% in EBIT margin. Rieter is indeed on track to embark...

Lynn Hautekeete ... (+2)
  • Lynn Hautekeete
  • Wim Lewi

Real Asset Conference Soundbites 19-20 March 2024

This note gathers feedback from the group meetings and the break-out sessions. In total 23 companies presented in group meetings and/or break-out sessions. More than 100 guests found their way to the venue and some more followed virtual meetings. Physical attendance is clearly on the rise after the COVID disruption. Investing remains a people's business. The 4 break-out sessions made for informative additions to the C-level meetings and a nice platform for discussion. Tuesday morning concentrate...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch